Cargando…

Factors impacting quality of life in multiple system atrophy

BACKGROUND: Multiple system atrophy (MSA) is an atypical parkinsonian disorder marked by autonomic dysfunction, parkinsonism, cerebellar dysfunction, and poor response to dopaminergic medications such as levodopa. Patient-reported quality of life is an important benchmark for clinicians and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Nabila, Nesspor, Vanessa, Bang, Jee, Scholz, Sonja W., Pantelyat, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036583/ https://www.ncbi.nlm.nih.gov/pubmed/36970533 http://dx.doi.org/10.3389/fneur.2023.1111605

Ejemplares similares

Bereitschaftspotential in Multiple System Atrophy
por: Yang, Yi-Chien, et al.
Publicado: (2021)

Rhythmic auditory cueing in atypical parkinsonism: A pilot study
por: Pantelyat, Alexander, et al.
Publicado: (2022)

Editorial: Autonomic dysfunction in multiple system atrophy
por: Yamamoto, Tatsuya, et al.
Publicado: (2022)

Cerebral Metabolism Related to Cognitive Impairments in Multiple System Atrophy
por: Shen, Cong, et al.
Publicado: (2021)

Prospective CERAD Neuropsychological Assessment in Patients With Multiple System Atrophy
por: Maass, Fabian, et al.
Publicado: (2022)

Relationship Between Pneumonia and Dysphagia in Patients With Multiple System Atrophy
por: Wada, Ayako, et al.
Publicado: (2022)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

The differences of orthostatic hypotension in patients with Parkinson's disease and multiple system atrophy
por: Zeng, Jingrong, et al.
Publicado: (2023)

Constipation in multiple system atrophy: a pilot study in Chinese patients
por: Chen, Yalan, et al.
Publicado: (2023)

The characteristics and alteration of peripheral immune function in patients with multiple system atrophy
por: Wang, Minghui, et al.
Publicado: (2023)

The Characteristics of Tremor Motion Help Identify Parkinson's Disease and Multiple System Atrophy
por: Su, Dongning, et al.
Publicado: (2020)

Cognitive Profile and Its Evolution in a Cohort of Multiple System Atrophy Patients
por: Sambati, Luisa, et al.
Publicado: (2020)

Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers
por: Goolla, Meghana, et al.
Publicado: (2023)

Multiple System Atrophy – Cerebellar Type: Clinical Picture and Treatment of an Often-Overlooked Disorder
por: Ortiz, Juan Fernando, et al.
Publicado: (2020)

REM Sleep Behaviour Disorder in Multiple System Atrophy: From Prodromal to Progression of Disease
por: Giannini, Giulia, et al.
Publicado: (2021)

Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2019)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study
por: Cuoco, Sofia, et al.
Publicado: (2021)

Cognitive and Autonomic Dysfunction in Multiple System Atrophy Type P and C: A Comparative Study
por: Lazzeri, Giulia, et al.
Publicado: (2022)

Histopathological Features of Gerhardt Syndrome in a Patient With Multiple System Atrophy: An Autopsy Case Report
por: Nakahara, Keiichi, et al.
Publicado: (2022)

Rethinking the reliability and accuracy of biomarkers in CNS-originating EVs for Parkinson's disease and multiple system atrophy
por: Taha, Hash Brown
Publicado: (2023)

An update on advances in magnetic resonance imaging of multiple system atrophy
por: Chelban, Viorica, et al.
Publicado: (2018)

Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment—A Pilot Study
por: Thimm, Andreas, et al.
Publicado: (2022)

The Shaking Palsy of the Larynx—Potential Biomarker for Multiple System Atrophy: A Pilot Study and Literature Review
por: Warnecke, Tobias, et al.
Publicado: (2019)

A case of familial frontotemporal dementia caused by a progranulin gene mutation
por: Currens, Lauryn, et al.
Publicado: (2023)

Loss of DARPP-32 and calbindin in multiple system atrophy
por: Hayakawa, Hideki, et al.
Publicado: (2013)

The language profile in multiple system atrophy: an exploratory study
por: Cuoco, Sofia, et al.
Publicado: (2021)

Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy
por: Campese, Nicole, et al.
Publicado: (2021)

MR imaging in multiple system atrophy: Its role in “splitting” parkinsonism
por: Vijayan, J., et al.
Publicado: (2008)

Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome
por: von Lewinski, Friederike, et al.
Publicado: (2013)

Elevated Percentage of CD3(+) T-Cells and CD4(+)/CD8(+) Ratios in Multiple System Atrophy Patients
por: Cao, Bei, et al.
Publicado: (2020)

Quantitative Validation of a Visual Rating Scale for Defining High-Iron Putamen in Patients With Multiple System Atrophy
por: Lee, Myung Jun, et al.
Publicado: (2019)

Cognition in Patients With Multiple System Atrophy (MSA) and Its Neuroimaging Correlation: A Prospective Case-Control Study
por: Dash, Santosh, et al.
Publicado: (2022)

Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy
por: Hu, Wen-Zheng, et al.
Publicado: (2023)

Dynamic postural balance indices can help discriminate between patients with multiple system atrophy and Parkinson's disease
por: Bao, Wei, et al.
Publicado: (2023)

Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study
por: Tamura, Mitsuyoshi, et al.
Publicado: (2023)

Genetic players in multiple system atrophy: unfolding the nature of the beast
por: Stemberger, Sylvia, et al.
Publicado: (2011)

Gray Matter Atrophy to Explain Subclinical Oculomotor Deficit in Multiple Sclerosis
por: Kincses, Bálint, et al.
Publicado: (2019)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2020)

Differential Diagnosis of Multiple System Atrophy-Parkinsonism and Parkinson's Disease Using α-Synuclein and External Anal Sphincter Electromyography
por: Cao, Zhentang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g5jjtf7l5v08rmt34pvl5oovvp